TY  - GEN
T1  - The CcdB toxin is an efficient selective marker for CRISPR-plasmids developed for genome editing in cyanobacteria
AU  - Menestreau, Martin
AU  - Rachedi, Raphaël
AU  - Risoul, Véronique
AU  - Foglino, Maryline
AU  - Latifi, Amel
DO  - 10.17912/micropub.biology.000512
UR  - http://beta.micropublication.org/journals/biology/micropub-biology-000512/
AB  - Recently, several CRISPR-based plasmids for editing cyanobacterial genomes have been developed. They derive mostly from vectors containing the low-copy number RSF1010 replication origin, and are of large size (> 10 kB). For instance, a CRISPR editing plasmid expressing the Cpf1 nuclease from Francisella novicida has been developed and shown to be efficient for editing cyanobacterial genomes (Ungerer and Pakrasi 2016). Later, this plasmid has been improved, notably by introducing the sacB counter-selection marker to optimize the loss of the editing plasmid once the genome-editing achieved (Niu et al. 2019). These plasmids are powerful tools, as their use has significantly decreased the time required to obtain mutants in cyanobacterial model strains. However, it has been largely reported that cloning in plasmids bearing the RSF1010 replication origin is difficult using techniques relying both on restriction enzymes, and approaches based on isothermal assembly. The copy number of RSF1010-type plasmids has been evaluated to be between 0.5 to 11.8 in Escherichia coli (Jahn et al. 2016), which explains the low yield of DNA obtained after plasmid extraction, and ineffective use in cloning procedures. In addition, the ability of RSF1010 plasmids to self-mobilize has also been suggested to explain their poor use as cloning-vectors (Taton et al. 2014). For all these reasons, we decided to first test our ability to manipulate the Cpf1-CRISPR plasmids by deleting the hetR gene of Nostoc PCC 7120 because the phenotype of the mutant is well defined (see below). In our hands, the cloning of the spacer was not a limiting-step due to the possibility of identification of positive clones by alpha-complementation (Ungerer and Pakrasi 2016). However, the insertion of the recombination platform (RP) –which contains the regions upstream and downstream to the gene to be deleted- was rather difficult, as a high number of negative clones are usually obtained (our success rate was less than 5%). In order to improve the cloning-success with this plasmid, we sought to introduce a screen that would allow direct selection of recombinant clones that have integrated the RP. To do this, we modified the plasmids pCpf1b (conferring resistance to kanamycin/neomycin) and pCpf1–sp (conferring resistance to spectinomycin) (Niu et al. 2019) by introducing the ccdB gene encoding a toxin that inhibits the DNA gyrase activity (Bernard and Couturier 1992). For this, the ccdB gene under the control of the pBAD promoter was amplified from the NM580 strain (Battesti et al. 2015) and cloned into the BamHI site of pCpf1b and pCpf1-sp plasmids. The XL1 Blue strain producing the anti-toxin CcdA was used for this experiment to inhibit the action of CcdB (Bernard and Couturier 1992). Over 100 colonies screened only 2 had the ccdB gene. A map of the obtained recombinant plasmid when pCpf1b was modified, is shown in Figure 1A. For the use of this plasmid for gene editing, the RP must be cloned between the BamHI sites, thus replacing the ccdB gene. This cloning must be performed in a strain that does not express the ccdA anti-toxin gene and arabinose must be added to the medium to induce expression of the toxin-encoding gene. Therefore, only clones that have integrated the RP are viable as the negative clones are counter-selected by the CcdB-induced lethality.
PY  - 2022
JO  - microPublication Biology
ER  -